Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Moderna, Inc. - Common Stock (NQ:MRNA)

29.58 +0.89 (+3.10%)
Streaming Delayed Price Updated: 10:37 AM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Moderna, BioNTech and Novavax stocks popped after the CDC noted a recent increase in positive Covid tests. 
Via Investor's Business Daily
S&P 500, Nasdaq Fall As Economic Data, Bond Yields Weigh
Stocks are mostly lower today, with the S&P 500 Index and Nasdaq Composite Index erasing early-morning gains. 
Via Talk Markets
Topics Stocks Stocks / Equities
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses... 
Via Benzinga
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Spotlight on Moderna: Analyzing the Surge in Options Activity
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
Is Moderna Stock a Buy?
Via The Motley Fool
Investors Look Back at 2024
The S&P 500 had a great year. 
Via The Motley Fool
Topics Stocks
Why Moderna (MRNA) Stock Is Trading Higher
Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory illnesses across the United States. 
Via Benzinga
3 Growth Stocks That Could Skyrocket in 2025 and Beyond
The proverbial planets are aligning for these three companies, and their stocks. 
Via The Motley Fool
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street.
Shares of this specialty technology company have gained 141% over the past year, and that could be just the beginning. 
Via The Motley Fool
Topics Initial Public Offering
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus
U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade. 
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Dec. 21
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Topics Stocks / Equities
3 Stocks That Could Turn $1,000 into $5,000 by 2030
Via The Motley Fool
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS. 
Via Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Wall Street began Tuesday’s session on a weaker note, with major indices slipping after November's robust retail sales report reignited investor concerns that the Federal Reserve might hold back... 
Via Benzinga
Topics Economy
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Super Micro Computer's stock is trading below its 50-day moving average ahead of its removal from the Nasdaq 100 Index on Dec. 23, 2024. The company faces delisting concerns and is seeking to raise... 
Via Benzinga
Nasdaq 100 Shakeup: 3 Stocks That Can Gain
Three stocks have their price targets above current price levels. 
Via Talk Markets
Topics Stocks / Equities
What's Going On Moderna Stock On Monday?
Moderna faces index removal, stock plunge, vaccine challenges, and lawsuits, while focusing on R&D in oncology and rare diseases for future growth. 
Via Benzinga
Topics Lawsuit
What's Going On With Super Micro Computer Shares Monday?
Super Micro is expected to be removed from the Nasdaq 100 Index later this month. 
Via Benzinga
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone. 
Via Benzinga
Topics Economy
Why I Can't Stop Buying This Ultra-High-Yielding ETF
Via The Motley Fool
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know
Palantir stock's huge rise this year has earned it a spot on another stock index. 
Via The Motley Fool
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
The much-awaited reconstitution of the Nasdaq 100 index has taken place, resulting in the addition of Bitcoin (CRYPTO: BTC) proxy MicroStrategy Inc. (NASDAQ:MSTR), Palantir Technologies Inc. (NASDAQ: 
Via Benzinga
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
Avian flu continues to spread with cases in cats, horses, and humans. Scientists monitor wildlife infections. Vaccine development may face challenges. 
Via Benzinga
Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?
Will Moderna, Super Micro get the axe in the annual rebalancing? 
Via Investor's Business Daily
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.